Your browser doesn't support javascript.
loading
Anti-Cancer Effects of Pristimerin and the Mechanisms: A Critical Review.
Li, Jia-Jun; Yan, Yan-Yan; Sun, Hong-Mei; Liu, Yun; Su, Chao-Yue; Chen, Hu-Biao; Zhang, Jian-Ye.
Affiliation
  • Li JJ; Guangdong Provincial Key Laboratory of Molecular Target & Clinical Pharmacology, School of Pharmaceutical Sciences and the Fifth Affiliated Hospital, Guangzhou Medical University, Guangzhou, China.
  • Yan YY; Institute of Respiratory and Occupational Diseases, Collaborative Innovation Center for Cancer, Medical College, Shanxi Datong University, Datong, China.
  • Sun HM; School of Chinese Medicine, Hong Kong Baptist University, Hong Kong, China.
  • Liu Y; Infinitus (China) Company Ltd., Jiangmen, China.
  • Su CY; Guangdong Provincial Key Laboratory of Molecular Target & Clinical Pharmacology, School of Pharmaceutical Sciences and the Fifth Affiliated Hospital, Guangzhou Medical University, Guangzhou, China.
  • Chen HB; Guangdong Provincial Key Laboratory of Molecular Target & Clinical Pharmacology, School of Pharmaceutical Sciences and the Fifth Affiliated Hospital, Guangzhou Medical University, Guangzhou, China.
  • Zhang JY; School of Chinese Medicine, Hong Kong Baptist University, Hong Kong, China.
Front Pharmacol ; 10: 746, 2019.
Article in En | MEDLINE | ID: mdl-31354475
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Front Pharmacol Year: 2019 Document type: Article Affiliation country: Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Front Pharmacol Year: 2019 Document type: Article Affiliation country: Country of publication: